Works matching AU Ma, Junxun

Results: 22

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1147903

By:

Wenyu Yang;
Tao Li;
Yibing Bai;
Yaping Long;
Ming Gao;
Ting Wang;
Fangfang Jing;
Fan Zhang;
Haitao Tao;
Junxun Ma;
Lijie Wang;
Yi Hu

Publication type:

Article

Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920970049

By:

Zhang, Zhibo;
Zhang, Fan;
Yuan, Fang;
Li, Ye;
Ma, Junxun;
Ou, Qiuxiang;
Liu, Zhefeng;
Yang, Bo;
Wang, Lijie;
Tao, Haitao;
Zhang, Sujie;
Li, Xiaoyan;
Zhi, Xiaoyu;
Ge, Xiangwei;
Bao, Hua;
Wu, Xue;
Hu, Yi;
Wang, Jinliang

Publication type:

Article

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920922033

By:

Cui, Pengfei;
Huang, Di;
Wu, Zhaozhen;
Tao, Haitao;
Zhang, Sujie;
Ma, Junxun;
Liu, Zhefeng;
Wang, Jinliang;
Huang, Ziwei;
Chen, Shixue;
Zheng, Xuan;
Hu, Yi

Publication type:

Article

Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-03095-z

By:

Liu, Qingyan;
Zhang, Weidong;
Pei, Yanbin;
Tao, Haitao;
Ma, Junxun;
Li, Rong;
Zhang, Fan;
Wang, Lijie;
Shen, Leilei;
Liu, Yang;
Jia, Xiaodong;
Hu, Yi

Publication type:

Article

Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer.

Published in:

Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08125-3

By:

Gao, Ming;
Zhang, Xia;
Yan, Huan;
Sun, Decong;
Yang, Xuejiao;
Yuan, Fang;
Ju, Yanfang;
Wang, Lijie;
Wang, Jinliang;
Zhao, Wei;
Zhang, Dong;
Li, Lin;
Xu, Xiaoyun;
Ma, Junxun;
Hu, Yi;
Zhang, Xiaotao

Publication type:

Article

Bevacizumab plus chemotherapy versus chemotherapy alone for preventing brain metastasis derived from advanced lung cancer.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2016, v. 28, n. 3, p. 218, doi. 10.1179/1973947815Y.0000000045

By:

Fu, Yan;
Hu, Jia;
Du, Nan;
Jiao, Shunchang;
Li, Fang;
Li, Xiaosong;
Ma, Junxun;
Zhao, Hui;
Kang, Huanrong

Publication type:

Article

Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.

Published in:

Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01173

By:

Zhang, Zhibo;
Yuan, Fang;
Chen, Runzhe;
Li, Ye;
Ma, Junxun;
Yan, Xiang;
Wang, Lijie;
Zhang, Fan;
Tao, Haitao;
Guo, Dong;
Huang, Zhiyue;
Zhang, Sujie;
Li, Xiaoyan;
Zhi, Xiaoyu;
Ge, Xiangwei;
Hu, Yi;
Wang, Jinliang

Publication type:

Article

Swainsonine Inhibits Invasion and the EMT Process in Esophageal Carcinoma Cells by Targeting Twist1.

Published in:

Oncology Research, 2018, v. 26, n. 8, p. 1207, doi. 10.3727/096504017X15046134836575

By:

Junxun Ma;
Lijie Wang;
Jinyu Li;
Guoqing Zhang;
Haitao Tao;
Xiaoyan Li;
Danyang Sun;
Yi Hu

Publication type:

Article

Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11709-1

By:

Wang, Yanrong;
Li, Lingling;
Hu, Jia;
Zhao, Yan;
Yan, Huan;
Gao, Ming;
Yang, Xuejiao;
Zhang, Xia;
Ma, Junxun;
Dai, Guanghai

Publication type:

Article

Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients.

Published in:

Cancer Medicine, 2019, v. 8, n. 4, p. 1350, doi. 10.1002/cam4.1839

By:

Yang, Bo;
Li, Jie;
Li, Fang;
Zhou, Hongxia;
Shi, Weiwei;
Shi, Huaiyin;
Sun, Shengjie;
Sun, Wending;
Wang, Jinliang;
Ma, Junxun;
Yan, Xiang;
Hu, Yi;
Jiao, Shunchang

Publication type:

Article

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study.

Published in:

Cancer Medicine, 2018, v. 7, n. 8, p. 4115, doi. 10.1002/cam4.1579

By:

Liu, Zhefeng;
Ma, Junxun;
Qian, Yuanyu;
Zhang, Fan;
Han, Chun;
Long, Yaping;
Li, Ye;
Zheng, Xuan;
Sun, Danyang;
Zhang, Jing;
Jiao, Shunchang;
Hu, Yi;
Cui, Pengfei;
Wang, Guoqiang;
Cai, Shangli

Publication type:

Article

Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.

Published in:

Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359241311058

By:

Gao, Ming;
Zhang, Xia;
Yan, Huan;
Zhao, Yan;
Yuan, Fang;
Sun, Decong;
Yang, Xuejiao;
Ju, Yanfang;
Wang, Lijie;
Tao, Haitao;
Tian, Luyuan;
Zhao, Changhong;
Ma, Junxun;
Hu, Yi;
Liu, Zhefeng

Publication type:

Article

Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 2971, doi. 10.1007/s00262-021-02852-4

By:

Wu, Zhaozhen;
Tao, Haitao;
Zhang, Sujie;
Wang, Xiao;
Ma, Junxun;
Li, Ruixin;
Liu, Zhefeng;
Wang, Jinliang;
Cui, Pengfei;
Chen, Shixue;
Di, Huang;
Huang, Ziwei;
Zheng, Xuan;
Hu, Yi

Publication type:

Article

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 365, doi. 10.1007/s00262-019-02452-3

By:

Ma, Junxun;
Sun, Danyang;
Wang, Jinliang;
Han, Chun;
Qian, Yuanyu;
Chen, Guangying;
Li, Xiaoyan;
Zhang, Juan;
Cui, Pengfei;
Du, Wushuang;
Wu, Zhaozhen;
Chen, Shixue;
Zheng, Xuan;
Yue, Zhichao;
Song, Jia;
Gao, Chan;
Cai, Shangli;
Hu, Yi

Publication type:

Article

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1527, doi. 10.1007/s00262-019-02386-w

By:

Sun, Danyang;
Ma, Junxun;
Wang, Jinliang;
Han, Chun;
Qian, Yuanyu;
Chen, Guangying;
Li, Xiaoyan;
Zhang, Juan;
Cui, Pengfei;
Du, Wushuang;
Wu, Zhaozhen;
Chen, Shixue;
Zheng, Xuan;
Yue, Zhichao;
Song, Jia;
Gao, Chan;
Zhao, Xiaochen;
Cai, Shangli;
Hu, Yi

Publication type:

Article

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors.

Published in:

Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/1179554921996288

By:

Wu, Zhaozhen;
Cui, Pengfei;
Tao, Haitao;
Zhang, Sujie;
Ma, Junxun;
Liu, Zhefeng;
Wang, Jinliang;
Qian, Yuanyu;
Chen, Shixue;
Huang, Ziwei;
Zheng, Xuan;
Huang, Di;
Hu, Yi

Publication type:

Article

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors.

Published in:

Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/1179554921996288

By:

Zhaozhen Wu;
Pengfei Cui;
Haitao Tao;
Sujie Zhang;
Junxun Ma;
Zhefeng Liu;
Jinliang Wang;
Yuanyu Qian;
Shixue Chen;
Ziwei Huang;
Xuan Zheng;
Di Huang;
Yi Hu

Publication type:

Article

XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer.

Published in:

Medical Science Monitor, 2018, v. 24, p. 2858, doi. 10.12659/MSM.904935

By:

Lijie Wang;
Junxun Ma;
Bo Yang;
Fangfang Jing;
Yi Hu

Publication type:

Article

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.562315

By:

Chen, Shixue;
Zhang, Zhibo;
Zheng, Xuan;
Tao, Haitao;
Zhang, Sujie;
Ma, Junxun;
Liu, Zhefeng;
Wang, Jinliang;
Qian, Yuanyu;
Cui, Pengfei;
Huang, Di;
Huang, Ziwei;
Wu, Zhaozhen;
Hu, Yi

Publication type:

Article

Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.585271

By:

Shang, Jin;
Han, Xiao;
Zha, Haoran;
Tao, Haitao;
Li, Xiaoyan;
Yuan, Fang;
Chen, Guangying;
Wang, Lijie;
Ma, Junxun;
Hu, Yi

Publication type:

Article

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort.

Published in:

2018

By:

Sun, Danyang;
Ma, Junxun;
Wang, Jinliang;
Zhang, Fan;
Wang, Lijie;
Zhang, Sujie;
Chen, Guangying;
Li, Xiaoyan;
Du, Wushuang;
Cui, Pengfei;
Hu, Yi

Publication type:

journal article

Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer.

Published in:

2020

By:

Huang, Di;
Zhang, Fan;
Tao, Haitao;
Zhang, Sujie;
Ma, Junxun;
Wang, Jinliang;
Liu, Zhefeng;
Cui, Pengfei;
Chen, Shixue;
Huang, Ziwei;
Wu, Zhaozhen;
Zhao, Lei;
Hu, Yi

Publication type:

journal article